Literature DB >> 20159855

Contraction-related stimuli regulate GLUT4 traffic in C2C12-GLUT4myc skeletal muscle cells.

Wenyan Niu1, Philip J Bilan, Shuhei Ishikura, Jonathan D Schertzer, Ariel Contreras-Ferrat, Zhengxiang Fu, Jie Liu, Shlomit Boguslavsky, Kevin P Foley, Zhi Liu, Jinru Li, Guilan Chu, Thomas Panakkezhum, Gary D Lopaschuk, Sergio Lavandero, Zhi Yao, Amira Klip.   

Abstract

Muscle contraction stimulates glucose uptake acutely to increase energy supply, but suitable cellular models that faithfully reproduce this complex phenomenon are lacking. To this end, we have developed a cellular model of contracting C(2)C(12) myotubes overexpressing GLUT4 with an exofacial myc-epitope tag (GLUT4myc) and explored stimulation of GLUT4 traffic by physiologically relevant agents. Carbachol (an acetylcholine receptor agonist) induced a gain in cell surface GLUT4myc that was mediated by nicotinic acetylcholine receptors. Carbachol also activated AMPK, and this response was sensitive to the contractile myosin ATPase inhibitor N-benzyl-p-toluenesulfonamide. The gain in surface GLUT4myc elicited by carbachol or by the AMPK activator 5-amino-4-carboxamide-1 beta-ribose was sensitive to chemical inhibition of AMPK activity by compound C and partially reduced by siRNA-mediated knockdown of AMPK catalytic subunits or LKB1. In addition, the carbachol-induced gain in cell surface GLUT4myc was partially sensitive to chelation of intracellular calcium with BAPTA-AM. However, the carbachol-induced gain in cell surface GLUT4myc was not sensitive to the CaMKK inhibitor STO-609 despite expression of both isoforms of this enzyme and a rise in cytosolic calcium by carbachol. Therefore, separate AMPK- and calcium-dependent signals contribute to mobilizing GLUT4 in response to carbachol, providing an in vitro cell model that recapitulates the two major signals whereby acute contraction regulates glucose uptake in skeletal muscle. This system will be ideal to further analyze the underlying molecular events of contraction-regulated GLUT4 traffic.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159855     DOI: 10.1152/ajpendo.00773.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  18 in total

1.  Influence of statins on distinct circulating microRNAs during prolonged aerobic exercise.

Authors:  Pil-Ki Min; Joseph Park; Stephanie Isaacs; Beth A Taylor; Paul D Thompson; Chris Troyanos; Pierre D'Hemecourt; Sophia Dyer; Stephen Y Chan; Aaron L Baggish
Journal:  J Appl Physiol (1985)       Date:  2015-10-15

2.  Capsaicin induces apoptosis in human osteosarcoma cells through AMPK-dependent and AMPK-independent signaling pathways.

Authors:  Hui Ying; Zhi Wang; Yan Zhang; Tie-Yi Yang; Zhi-Hong Ding; Shu-Yi Liu; Jin Shao; Yue Liu; Xin-Bing Fan
Journal:  Mol Cell Biochem       Date:  2013-09-05       Impact factor: 3.396

3.  Liraglutide ameliorates palmitate-induced insulin resistance through inhibiting the IRS-1 serine phosphorylation in mouse skeletal muscle cells.

Authors:  Z Li; Y Zhu; C Li; Y Tang; Z Jiang; M Yang; C-L Ni; D Li; L Chen; W Niu
Journal:  J Endocrinol Invest       Date:  2018-01-27       Impact factor: 4.256

4.  Synthetic (+)-antroquinonol exhibits dual actions against insulin resistance by triggering AMP kinase and inhibiting dipeptidyl peptidase IV activities.

Authors:  C Y Hsu; R S Sulake; P-K Huang; H-Y Shih; H-W Sie; Y-K Lai; C Chen; C F Weng
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

5.  Rac-1 superactivation triggers insulin-independent glucose transporter 4 (GLUT4) translocation that bypasses signaling defects exerted by c-Jun N-terminal kinase (JNK)- and ceramide-induced insulin resistance.

Authors:  Tim Ting Chiu; Yi Sun; Alexandra Koshkina; Amira Klip
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

6.  Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells.

Authors:  Nicolas J Pillon; Scott Frendo-Cumbo; Maya R Jacobson; Zhi Liu; Paul L Milligan; Hai Hoang Bui; Juleen R Zierath; Philip J Bilan; Joseph T Brozinick; Amira Klip
Journal:  J Lipid Res       Date:  2018-05-23       Impact factor: 5.922

7.  Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle.

Authors:  D Lee Hamilton; Craig Beall; Stewart Jeromson; Cyrille Chevtzoff; Daniel J Cuthbertson; Michael L J Ashford
Journal:  J Physiol Sci       Date:  2013-09-17       Impact factor: 2.781

8.  Rac1 is a novel regulator of contraction-stimulated glucose uptake in skeletal muscle.

Authors:  Lykke Sylow; Thomas E Jensen; Maximilian Kleinert; Joshua R Mouatt; Stine J Maarbjerg; Jacob Jeppesen; Clara Prats; Tim T Chiu; Shlomit Boguslavsky; Amira Klip; Peter Schjerling; Erik A Richter
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

9.  Shikonin increases glucose uptake in skeletal muscle cells and improves plasma glucose levels in diabetic Goto-Kakizaki rats.

Authors:  Anette I Öberg; Kamal Yassin; Robert I Csikasz; Nodi Dehvari; Irina G Shabalina; Dana S Hutchinson; Mona Wilcke; Claes-Göran Östenson; Tore Bengtsson
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

10.  Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.

Authors:  James Boon; Andrew J Hoy; Romana Stark; Russell D Brown; Ruth C Meex; Darren C Henstridge; Simon Schenk; Peter J Meikle; Jeffrey F Horowitz; Bronwyn A Kingwell; Clinton R Bruce; Matthew J Watt
Journal:  Diabetes       Date:  2012-11-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.